全文获取类型
收费全文 | 821458篇 |
免费 | 90154篇 |
国内免费 | 1531篇 |
出版年
2018年 | 8428篇 |
2017年 | 7685篇 |
2016年 | 11166篇 |
2015年 | 15382篇 |
2014年 | 17918篇 |
2013年 | 25052篇 |
2012年 | 28157篇 |
2011年 | 28306篇 |
2010年 | 19159篇 |
2009年 | 17401篇 |
2008年 | 24719篇 |
2007年 | 25200篇 |
2006年 | 23708篇 |
2005年 | 22798篇 |
2004年 | 22564篇 |
2003年 | 21641篇 |
2002年 | 20796篇 |
2001年 | 38597篇 |
2000年 | 38758篇 |
1999年 | 30668篇 |
1998年 | 10533篇 |
1997年 | 10930篇 |
1996年 | 10261篇 |
1995年 | 9909篇 |
1994年 | 9617篇 |
1993年 | 9392篇 |
1992年 | 24840篇 |
1991年 | 24100篇 |
1990年 | 23481篇 |
1989年 | 22835篇 |
1988年 | 21185篇 |
1987年 | 19782篇 |
1986年 | 18331篇 |
1985年 | 18156篇 |
1984年 | 15054篇 |
1983年 | 12560篇 |
1982年 | 9531篇 |
1981年 | 8494篇 |
1980年 | 7944篇 |
1979年 | 13487篇 |
1978年 | 10493篇 |
1977年 | 9436篇 |
1976年 | 8536篇 |
1975年 | 9503篇 |
1974年 | 10124篇 |
1973年 | 10023篇 |
1972年 | 8955篇 |
1971年 | 8163篇 |
1970年 | 6973篇 |
1969年 | 6738篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Gerald E. Gaull M.D. 《Neurochemical research》1996,21(10):1267-1268
55.
56.
Chungwen Wei Eugene Storozynsky A. J. McAdam Kun-Yun Yeh Brian R. Tilton Richard A. Willis Richard K. Barth R. John Looney Edith M. Lord J. G. Frelinger 《Cancer immunology, immunotherapy : CII》1996,42(6):362-368
Human prostate-specific antigen (PSA) has a highly restricted tissue distribution. Its expression is essentially limited
to the epithelial cells of the prostate gland. Moreover, it continues to be synthesized by prostate carcinoma cells. This
makes PSA an attractive candidate for use as a target antigen in the immunotherapy of prostate cancer. As a first step in
characterizing the specific immune response to PSA and its potential use as a tumor-rejection antigen, we have incorporated
PSA into a well-established mouse tumor model. Line 1, a mouse lung carcinoma, and P815, a mouse mastocytoma, have been transfected
with the cDNA for human PSA. Immunization with a PSA-expressing tumor cell line demonstrated a memory response to PSA which
protected against subsequent challenge with PSA-expressing, but not wild-type, tumors. Tumor-infiltrating lymphocytes could
be isolated from PSA-expressing tumors grown in naive hosts and were specifically cytotoxic against a syngeneic cell line
that expressed PSA. Immunization with tumor cells resulted in the generation of primary and memory cytotoxic T lymphocytes
(CTL) specific for PSA. The isolation of PSA-specific CTL clones from immunized animals further demonstrated that PSA can
serve as a target antigen for antitumor CTL. The immunogenicity studies carried out in this mouse tumor model provide a rationale
for the design of methods to elicit PSA-specific cell-mediated immunity in humans.
Received: 4 April 1996 / Accepted: 31 May 1996 相似文献
57.
58.
OBJECTIVES--To compare the effectiveness of penicillin V and amoxycillin with placebo in treatment of adult patients with acute sinusitis. DESIGN--Randomised, double blind, placebo controlled trial. SETTING--Norwegian general practice. SUBJECTS--130 adult patients with a clinical diagnosis of acute sinusitis confirmed by computed tomography. MAIN OUTCOME MEASURES--Subjective status after three and 10 days of treatment, difference in clinical severity score between day 0 and day 10 as evaluated by the general practitioner, difference in score from computed tomography on day 0 and day 10, and duration of sinusitis. RESULTS--Amoxycillin and penicillin V led to significantly faster and better recovery than placebo. By day 10, 71 patients receiving antibiotic treatment- (86%) considered themselves to be recovered or much better compared with 25 (57%) receiving placebo. The mean (95% confidence interval) reductions in clinical severity scores by day 10 were 5.4 (5.0 to 5.8) for penicillin V, 5.5 (4.9 to 6.0 for amoxycillin, and 3.4 (2.8 to 4.0) for placebo. For the antibiotic groups combined the number of patients with the greatest degree of improvement on computed tomography (scale 0-16)-that is, score 5-16 on day 10-was 31/83 (37%) compared with 10/44 (23%) receiving placebo. The median duration of the sinusitis was nine days in the amoxycillin group, 11 days in the penicillin V group, and 17 days in the placebo group. CONCLUSION--Penicillin V and amoxycillin are significantly more effective than placebo in the treatment of acute sinusitis. 相似文献
59.
M. Hagberg 《BMJ (Clinical research ed.)》1996,313(7054):419-422
60.